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1 Introduction 
The interactions of drugs with biological membranes affect the delivery of drugs to the 
target sites within the body. Usually, a drug has to cross several membranes in order to 
enter the target location. As a result, the optimization of the delivery of drugs requires 
understanding of the interactions of drugs with biological membranes. Knowledge of 
these interactions is also of prime importance when predicting adsorption, distribution, 
metabolism, and excretion (ADME) properties of drugs already in the early phases of 
drug discovery process. 
The most common physicochemical property used in the prediction of drug-membrane 
interactions is the lipophilicity of a drug, which is usually expressed as log P, the 
logarithm of the partition coefficient between two immiscible solvents. Traditionally, 
the partition coefficient has been determined using n-octanol and water. However, the 
ability of the octanol−water partition coefficient to describe drug partitioning has been 
questioned due to the major differences in the biophysical properties of octanol and 
phospholipid cell membrane. Due to this, alternative approaches, including both 
experimental and computational methods, have been developed. Because of the 
significance of the partition coefficient in the evaluation of drug-membrane interactions, 
a major part of this thesis is devoted to the development of new methods for the 
determination of the partition coefficient of drugs. The determination of the partition 
coefficient is approached experimentally using various physicochemical methods 
(Publications I, III and IV) as well as from a theoretical point of view.  
Physicochemical properties of the drugs are of utmost importance when considering the 
delivery of drugs to the target site. Yet equally important are the properties of the 
carriers which are used to improve the delivery and effectiveness of drugs. To minimize 
premature drug degradation, prevent undesirable side effects and increase the 
bioavailability of the drug, various drug delivery and drug targeting systems have been 
established, such as liposomes, micelles, synthetic polymers, and microspheres. 
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Liposomes are phospholipid vesicles that form spontaneously in aqueous environments. 
Drugs can be encapsulated either inside the aqueous cavity or within the phopholipid 
bilayer of the vesicle. The interaction of liposomes and drug molecules has been of 
interest mainly for two reasons: On one hand, because of their resemblance with 
biological membranes, liposomes have been used as model membranes to study 
interactions of drugs and phospholipids at cellular level. On the other hand, 
biocompatibility has allowed the use of liposomes as delivery systems in drug targeting. 
In this thesis, both of these aspects were considered, when the ability of liposomes to 
encapsulate β-blockers was studied (Publication I). 
Carriers of drugs are especially important in gene delivery. Various viral and non-viral 
gene delivery vehicles have recently been developed for the use of gene therapy. 
However, due to the safety concerns associated with viral vectors, such as their toxicity 
and potential for generating a strong immune response, non-viral DNA carriers have 
gained increasing interest. In addition to safety issues, the advantages of the non-viral 
gene delivery vehicles include the ease of their structure modification and low cost. 
Despite the advantages, a lot of research is still needed on non-viral vectors before they 
can be utilized in clinical applications as their efficiency is much lower when compared 
with the viral vectors. Publication II focuses on the physicochemical properties of the 
cationic polymer−plasmid DNA complexes of two commonly used polymers, their 
tendency to aggregate, and their interaction with the cell surface glycosaminoglycans 
(GAGs). The physicochemical origin of the complexation and aggregation described in 
Publication II may prove to be of great importance when the interactions of the 
complexes with biological membranes are evaluated and better gene delivery systems 
are developed.  
This thesis aims to highlight the value of physicochemical methods when studying 
drug−membrane interactions, with emphasis on the various physicochemical approaches 
in determining the partition coefficient of drugs. As the properties of the drug carriers 
are equally significant in drug delivery, attention is also focused on the physicochemical 
properties of drug carriers and their interactions with biological membranes. 
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2 Partitioning of drugs 
Before obtaining the therapeutic effect of a drug, the drug has to enter the body and 
reach the site of action. There are two main routes for drug permeation across the cell 
membrane: paracellular transport between the adjacent epithelial cells and transcellular 
route across the cells [1]. Transcellular processes can be further divided into passive 
diffusion and active transport, which requires specialized membrane proteins. Of these, 
the process of passive diffusion is in the focus of this thesis as it is the primary 
mechanism for most conventional drug molecules. Furthermore, the epithelial interface 
is usually assumed to act as a simple lipophilic barrier where the rate of absorption 
correlates with the lipophilicity of the drug. The drug lipophilicity is often measured by 
its partition coefficient Pi, which is defined as the ratio of the activity a species in two 
immiscible phases in equilibrium [2]: 
w
o
i
i
i a
aP =           (1) 
where oia is the activity in the oil phase and 
w
ia the activity in the aqueous phase.  
The partition coefficient is important not only in the absorption of the drug, but also in 
the other pharmacokinetic processes. Along with the structure of the drug and 
drug−receptor interactions, the pharmacokinetic ADME processes are the determining 
factors which govern the efficacy of the drug. In these processes, lipid solubility often 
plays a major role and thus the study of drug partitioning is a cornerstone for 
understanding the interactions of drugs with biological membranes. 
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2.1 Partitioning of ionized drugs 
Understanding the dissociation equilibrium and partitioning of electrolytes is of 
fundamental importance in drug delivery, as most drugs exist as weak acids or bases in 
the body. However, earlier it was commonly accepted that only neutral and non-polar 
compounds are able to penetrate the phospholipid membrane [3]. Even though ionic 
species were observed to diffuse across the biological membranes, the popular 
explanation for the phenomenon was that the ionized drugs form lipophilic ion pairs and 
enter the membrane in the neutral form [4,5]. Yet many later studies have shown that 
also ionized drugs permeate biological membranes [6−10]. Therefore, it is now 
recognized that the partition coefficients need to be determined not only for the neutral 
drug, but also for the ionized species. 
In the determination of partition coefficients for ionized drugs, the distribution of the 
ions between the aqueous phase and the lipid phase is of utmost significance. A general 
method for the calculation of the equilibrium values from the initial concentrations of 
the ions was first reported by Hung [11]. In the work of Hung, equations are presented 
for the determination of the Galvani potential difference when the concentrations, 
activity coefficients, standard Gibbs energies of transfer of ions, volumes of each phase 
and temperature are known. The theoretical treatment of ion partitioning, which takes 
into account the effect of the volume ratio of the two phases was continued by Kakiuchi 
[12]. The work of Kakiuchi examines the effect of complexation on the partition 
equilibria more closely and attention is also paid to the cases of limiting behavior when 
the volume ratio is extremely large or small. The works of Hung and Kakiuchi have 
previously been applied to the analysis of microemulsions, where the size of the droplet 
is comparable to the Debye length [13]. 
Here, the Galvani potential difference, phase volume ratio and pH are demonstrated to 
affect the partitioning of ionized drugs between two bulk phases. As in the general case 
of the equilibrium of ions in a system of two immiscible liquid phases, a Galvani 
potential difference across the aqueous and lipid phases is created when ions partition 
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into the biological membrane. This Galvani potential difference can be seen as a driving 
force for the partitioning of the ionized drugs and it can be related to the partition 
coefficients of the ionic forms of the drugs. Furthermore, the partition coefficient of an 
ionized drug is not an independent constant, but it is dependent on the volume ratio of 
the phases and the pH value of the surroundings. In addition, when studying the 
partitioning of ionized drugs, one has to keep in mind that the ionized form of the drug 
cannot penetrate the membrane alone, but a counter ion is always transferred with the 
ionized drug due to the electroneutrality condition. The purpose of the following 
sections is to show with straightforward examples and illustrative simulations how to 
evaluate the effects of the Galvani potential difference, phase volume ratio and pH in 
the case of partitioning of ionized drugs. As partitioning is defined between bulk phases, 
this treatment excludes the deviations from the electroneutrality, which take place in 
very thin electrical double layers at the interfaces of two phases.  
2.1.1 Galvani potential difference 
When ionized drugs partition into biological membranes, the Galvani potential 
difference is created. This is because the electrochemical potentials of the ion in the two 
phases, i.e. the aqueous phase outside the membrane and the lipid phase inside the 
membrane, are equal: 
ow μ~μ~ ii =           (2) 
The electrochemical potential can be expressed as the sum of a chemical and electrical 
term: 
www,0www lnμμμ~ φ++=φ+= FzaRTFz iiiiii      (3) 
where wμ i  is the chemical potential of the ion, zi the charge number of the ion, F the 
Faraday constant, and wφ  is the Galvani potential of the aqueous phase. On the right 
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hand side, 0,wμ i  represents the standard chemical potential and wia  the activity of the ion 
in the aqueous phase. R is the molar gas constant and T is temperature.  
The electrochemical potential can be written for the lipid phase in a similar manner. 
From the equality of the electrochemical potentials in the two phases, the Galvani 
potential difference can be expressed as: 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+
−
=φ−φ=φΔ
w
o0,w0,o
oww
o ln
μμ
i
i
ii
ii
a
a
Fz
RT
Fz
     (4) 
Equation (4) can be rewritten as: 
( )i
i
i
i
i
i
i PFz
RT
a
a
Fz
RT lnln 0wow
o
0w
o
w
o ⎟⎟⎠
⎞
⎜⎜⎝
⎛
+φΔ=⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+φΔ=φΔ     (5) 
where 0wo iφΔ  is the standard transfer potential of ion i, and Pi is its partition coefficient. 
The standard transfer potential is related to the Gibbs free energy of transfer, 0wo iGΔ  as 
follows: 
Fz
G
Fz i
i
i
ii
i
0w
o
0,o0,w
0w
o
μμ Δ
−=
−
−=φΔ        (6) 
The partition coefficient of a neutral drug can be calculated from the partition 
coefficient of the corresponding ionized form by subtracting the electrostatic 
contribution of the Gibbs free energy of transfer, which can be estimated as [14]: 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
ε
−
επε
≈Δ ow
0
A
22
0w
o
11
8 rr
es a
Nez
G         (7) 
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For an ion of the radius a = 0.3 nm Equation (7) gives ca. −20 kJ/mol*, which on log P 
scale means about −3.5 units. Hence, log P of an ionic species is usually negative. 
From Equations (5) and (6), the partition coefficient of the ionized drug is solved as 
[15]: 
⎟⎠
⎞⎜⎝
⎛ φΔ=⎟⎠
⎞⎜⎝
⎛ φΔ⎟⎟⎠
⎞
⎜⎜⎝
⎛ Δ
==
w
o
0w
o
0w
o
w
o
expexpexp
RT
Fz
P
RT
Fz
RT
G
a
a
P ii
ii
i
i
i    (8) 
In Equation (8), 0iP  is the standard partition coefficient, which depends only on the 
chemical structure of the ionized drug. Equation (8) shows, however, that the Galvani 
potential difference also affects the value of the partition coefficient of the drug between 
the two phases, and not just the chemical structure is responsible. Thus, it is evident that 
the partition coefficient of an ionized drug can be altered by changing the Galvani 
potential difference between the phases. Equation (8) for a neutral species (zi = 0) 
reduces to the usual form. In the following sections, illustrative simulations are used to 
elucidate the effects of the counter ion and the phase volume ratio on the Galvani 
potential and partitioning. 
2.1.2 Role of counter ion 
Because of the electroneutrality condition, a single ion cannot partition across two 
phases alone. In order for the electroneutrality condition to be fulfilled, the same 
amount of the opposite charges must be transported simultaneously. This means that the 
ionized drug always carries a counter ion with it, and thus partitioning of an ionized 
drug depends not only on the properties of the drug, but also on the properties of the 
                                                 
*This is the Born model, where e = elementary charge, 1.6×10−19 C, NA = Avogadro constant, 6.02×1023 
mol−1, 0ε = permittivity of free space, 8.854×10
−12 F m−1, rε = relative permittivity, taken as 78.4 for 
water and 10.0 for the organic phase. 
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counter ion. Although deviations from the electroneutrality are found in very thin 
electrical double layers at interfaces, partitioning is defined between bulk phases.  
Here, partitioning of 1-1 electrolyte is considered in order to exemplify the role of the 
counter ion. Writing Equation (2) for a cation and an anion gives: 
ooo0,www0, lnμlnμ φ++=φ++ ++++ FaRTFaRT      (9) 
ooo0,www0, lnμlnμ φ−+=φ−+
−−−−
FaRTFaRT      (10) 
As the electrochemical potential in one phase can be expressed as α
−
α
+
α
± += μ
~μ~μ~  (α is w 
or o), summing Equations (9) and (10) results in: 
( ) ( )2o0,o2w0,w lnμlnμ ±±±± +=+ aRTaRT       (11) 
and 
( )
−+
−
−
+
+±
±
±
±
±
±
±
± ==⎟⎟⎠
⎞
⎜⎜⎝
⎛ Δ
=⎟⎟⎠
⎞
⎜⎜⎝
⎛
γ
γ
=⎟⎟⎠
⎞
⎜⎜⎝
⎛
= PP
a
a
a
a
RT
G
c
c
a
aP w
o
w
o0w
o
2
w
o
w
o2
w
o
2 exp     (12) 
where c± is the mean concentration, ±a  the mean activity and ±γ  the mean activity 
coefficient that can be determined experimentally. This example shows the difference 
between the partitioning of a neutral and an ionized drug.  
Furthermore, an expression for the Galvani potential difference can be found by 
subtracting Equation (10) from Equation (9): 
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( ) ⎟⎟⎠
⎞
⎜⎜⎝
⎛
−=φΔ+φΔ≈
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+
Δ−Δ
−=φΔ
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+
−+
−+
−+−+
0
0
0w
o
0w
o
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wo0w
o
0w
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o
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2
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P
P
F
RT
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aa
F
RT
F
GG
      (13) 
In Equation (13), the approximation is due to the electroneutrality condition oo
−+ = cc  and 
ww
−+ = cc  and the fact that the ratio of the activity coefficients approaches unity much 
faster than any of the activity coefficients alone when the concentration approaches 
zero. The role of the counter ion in drug partitioning is clearly illustrated by Equation 
(13). It is not only the ionized drug that creates the Galvani potential difference, but the 
counter ion contributes to it as well. Thus the counter ion has a major effect on the 
measured value of the partition coefficient for an ionized drug. 
Moreover, understanding the role of the Galvani potential difference in partitioning of 
ionized drugs provides the means to control the partitioning phenomenon. The potential 
between the two phases can be adjusted simply by a common ion present in both phases. 
If the aqueous phase contains, say, an electrolyte C+A− and an organic phase an 
electrolyte C+B−, the common cation C+ fully determines the Galvani potential 
difference between the phases that is: 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+φΔ=φΔ
+
+
+ w
C
o
C0
C
w
o
w
o ln a
a
Fz
RT
i
       (14) 
In equation (14), the partitioning of the species A− and B− is assumed to be negligible. 
Adding some hydrophobic electrolyte into the organic phase is found to shift partition 
equilibria, which is often explained by ion-pairing in the organic phase, but as Girault 
and co-workers [15] have also pointed out, the reason more probably is the shift of the 
Galvani potential difference according to Equation (14). 
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The important role of the counter ion in drug delivery can be further illustrated by a 
thought experiment on solubility. Salicylic acid is soluble in water as such, and is 
partitioned between an organic and an aqueous phase, but if the hydrogen ion in it is 
replaced by a more hydrophobic cation, say, tetraethylammonium ion, the resulting 
tetraethylammonium salicylate no longer dissolves in water in significant amounts. This 
demonstrates why it is crucial to evaluate not only the partitioning of the ionized drug, 
but also that of the counter ion. Because of the electroneutrality condition, a single ion 
does not partition across two phases alone, but the same amount of the opposite charges 
must be transported simultaneously. 
2.1.3 Effect of phase volume ratio 
Partitioning of drugs may also depend on the volume ratio of the aqueous and lipid 
phases. The volume ratio not only affects the determination of the partition coefficients 
of the drugs in vitro, but it can also be of importance when the drug partitions the 
biological membrane in vivo as the volume of the lipid membrane is very small 
compared to the surrounding aqueous media.  
 
Figure 1. Scheme of partitioning of a weak electrolyte C+A− between an aqueous and an 
organic phase; ‘ip’ denotes an ion-pair. 
The situation is illustrated by partitioning of a weak electrolyte according to the scheme 
in Figure 1, where dissociation and partitioning equilibria are accompanied by the 
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pertinent equilibrium constants. Due to electroneutrality*, the dissociation constant of a 
weak electrolyte in the aqueous phase, wdK , can be written as: 
( )
w
2w
w
ww
w
d [CA]
][C
[CA]
][A][C +−+
==K        (15) 
where C+ denotes the cation and A- the anion. If the initial concentration of a weak 
electrolyte CA in the aqueous phase is denoted by c0, the mass balance at equilibrium is: 
( ) /rc ooww0 ][C  [CA] ][C  [CA] ++ +++=       (16) 
where r = Vw/Vo, the ratio of the phase volumes. Applying the dissociation and 
partitioning equilibria Equation (16) becomes: 
( ) ( )rPKrPc www /1[CA]/1[CA] dip0 ++++=       (17) 
where Pip denotes the partition coefficient of an ion-pair. Equation (17) is a second 
order polynomial of w[CA]  and can thus be easily solved, after which [C+]w is known 
from Equation (15). It is worth mentioning that in the case of partitioning of a single 1-1 
electrolyte, the partition coefficients P+ and P− are equal, because the Galvani potential 
difference compensates the difference between 0+P  and 0−P , and 00 −+−+ == PPPP .  
                                                 
*From here onwards, concentrations are used instead of activities, because the estimation of activity 
coefficients, although feasible, does not change the picture qualitatively. 
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Figure 2. Distribution coefficient of a weak electrolyte as a function of the phase 
volume ratio. Parameters: c0 = 1.0 mM, Pip = 10, P+ = 0.01 and Kd =10
−5 M. 
Figure 2 displays the distribution coefficient D as a function of the phase volume ratio. 
ww
oo
]CA[]C[
]CA[]C[
+
+
=
+
+
D          (18) 
With the chosen parameter values, D varies between 0.037 and 9.05. The origin of the 
dependence of D on the volume ratio is ion-pairing: if the electrolytes were completely 
dissociated in both phases, D would be equal to P+ = P− at all volume ratios r. 
2.1.4 Effect of pH 
The effect of pH on the distribution coefficient has traditionally been taken into account 
using the following equation [6]: 
pHp
pHp
DHD
a
a
101
10
−
−
+
+
=
+
K
KPP
D         (19) 
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where PD represents the partition coefficient of the neutral drug and +DHP  the partition 
coefficient of the protonated species.  
In the work of Avdeef et al. [6], the plots of log D as a function of pH, or the 
lipophilicity profiles, of four acidic and four basic drugs for octanol−water and 
liposomal membrane−water systems were compared. In their study, Avdeef et al. used 
the difference of pKa values in the aqueous and organic phases to calculate the partition 
coefficients for the ionized species. The results showed that as the drugs ionize, the 
partitioning into liposomal membranes is significantly higher than into octanol. The 
difference between the two systems was explained by the electrostatic interactions 
between the ionized drug and the zwitterionic phospholipid, even though the 
electrostatic contributions of the partition coefficients were not considered as such. 
Recently, Elsayed et al. [16] developed the potentiometric determination of lipid 
membrane−water partition coefficient further and added electrostatic corrections to the 
analytical procedure.  
Even though Equation (19) describes the changes in D as a function of pH quite 
accurately at some pH values, it fails to capture some aspects of the phenomenon as the 
effects of the Galvani potential difference and the counter ion have not been taken into 
account. Here, the effect of pH on the distribution coefficient is illustrated by 
considering the simultaneous partition dissociation equilibria depicted in Figure 3. A 
basic drug is added into the aqueous phase in the concentration cD and assumed to 
remain constant and pH is fixed. In addition, the concentration of the counter ion in the 
water phase is assumed to be constant cA, i.e. the aqueous buffer capacity is assumed to 
be very high. Proton partitioning is assumed to be negligible and ion-pairing in the oil 
phase is also neglected at first to allow a comparison with Equation (18). 
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Figure 3. Partitioning of a drug that is a weak acid. 
As the basic drug D dissociates, the concentrations in the aqueous phase in equilibrium 
are: 
D
w α[D] c=  and ( ) Dw α1][DH c−=+        (20) 
where α   is the degree of dissociation and cD is concentration of the drug. The 
concentrations of the counter ion A− and the ionized drug DH+ in the organic phase can 
be written as: 
ϕ−−
−
= ePc 0
AA
o][A          (21) 
( ) ϕϕ++ ++ −== ePceP 0DHD0DHwo α1][DH][DH      (22) 
where 0iP is the standard partition coefficient and 
ϕ±e  the potential dependent part of Pi 
)./( wo RTF φΔ=ϕ  Due to electroneutrality in the organic phase [A−]o = [DH+]o, and eϕ 
can be solved from Equations (21) and (22) as: 
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( )
2/1
0
DHD
0
AA
α1 ⎟
⎟
⎠
⎞
⎜⎜⎝
⎛
−
=
+
−ϕ
Pc
Pc
e         (23) 
For the neutral drug, the concentration in the organic phase is simply: 
DD
o α[D] Pc=           (24) 
Substituting Equation (23) into Equation (22) results in: 
( ) AD0A0DHo α1][DH ccPP −= −++        (25) 
Now the distribution coefficient can be written as: 
( )
D
A0
A
0
DHDww
oo
α1α
][DH[D]
][DH[D]
c
c
PPPD
−+−+=
+
+
=
+
+
     (26) 
Equation (26) can be rewritten using the Henderson-Hasselbalch equation as: 
pHp
pHp
D
A0
A
0
DH
pHp
D
a
a
a 101
10
101 −
−
− +
×⎟⎟⎠
⎞
⎜⎜⎝
⎛
+
+
=
−+
K
K
K
c
cPP
PD      (27) 
An acidic drug, such as salicylic acid, dissociates to D− and H+, and the counter ion of 
D− is C+. Now, knowing wda logp KK −= , Equation (27) is modified into the following 
form: 
pHp
D
C0
C
0
D
pHp
pHp
DH
aa
a
101101
10
−−
−
+
⎟⎟⎠
⎞
⎜⎜⎝
⎛
+
+
×
=
+−
KK
K c
cPP
PD        (28) 
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Resemblance of Equations (27) and (28) with Equation (19) is obvious, and in Figure 4 
these two equations are compared with varying the lipophilicity of the anion and cation 
via its partition coefficient. Parameters in Figure 4 are: 
3//,01.0,1000 DCDA
0
D
0
DHDHD
=====
−+ ccccPPPP . pKa of the basic drug is 9 and that of the 
acidic drug is 3. The values of 0
A
 
−
P = 0
C
 +P  are indicated in Figure 4.  
 
Figure 4. Distribution coefficient according to Eqs. (27) and (28): 
3//,01.0,1000 DCDA
0
D
0
DHDHD
=====
−+ ccccPPPP . Dotted lines represent Eq. (19) and the 
corresponding equation for an acidic drug. 
The Galvani potential difference created by partitioning can be calculated from 
Equation (23) as: 
( )pHp0
DHD
0
AAw
o
a101ln
2
ln
2
+−++⎟⎟⎠
⎞
⎜⎜⎝
⎛
=φΔ
+
− K
F
RT
Pc
Pc
F
RT      (29) 
Figure 5 shows the Galvani potential difference with the parameter values given above. 
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Figure 5. Galvani potential difference created by partitioning. 
3//,01.0,1000 DCDA
0
D
0
DHDHD
=====
−+ ccccPPPP . 
Figures 4 and 5 show that for a basic drug, the deviation from the generally used 
Equation (19) is due to the Galvani potential difference that is created by the 
partitioning of the ionic species. The deviation naturally does not exist at high pH where 
ionization is negligible, although the Galvani potential difference is not zero, hence, the 
theory has relevance mainly in oral delivery due to the low pH of the stomach. The 
distribution coefficient can deviate from the expected value by two orders of magnitude, 
since a Galvani potential difference of 100 mV means about 1.7 units on log P scale. 
For an acidic drug, however, ionization does not really have significance, because it 
takes place outside the physiological pH range, unless the pKa of the drug is very low, 
of the order of 1-2. Therefore, acidic drugs are not discussed any further. 
To finalize this analysis, the effect of the phase volume ratio is included. Also ion-
pairing in the oil phase is considered, which is substantial in a low permittivity medium. 
The concentration of the counter ion A−, cA, and pH are fixed due to high buffer 
capacity, but the drug concentrations depend on the mass balance; the initial drug 
concentration in the aqueous phase is cD. The mass balance for the drug is: 
( ) ( )oooowwwDw [DHA]][DH  [D] ][DH  [D] ++++= ++ VVcV    (30) 
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Applying the partitioning equilibria, the dissociation equilibrium in the aqueous phase, 
and the ion-pairing equilibrium in the oil phase, 
oo
o
o
a ][A][DH
[DHA]
−+
=K          (31) 
Equation (30) becomes: 
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⎡ ⎟⎠
⎞⎜⎝
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++++=
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−++ r
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0
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o
a
0
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w
D 1][H
11][DH    (32) 
ϕe takes essentially the same form as in Equation (23): 
2/1
0
DH
w
0
AA
][DH ⎟
⎟
⎠
⎞
⎜⎜⎝
⎛
=
+
−
+
ϕ
P
Pc
e         (33) 
Equations (32) and (33) contain only two unknowns, [DH+]w and ϕe , hence the problem 
is solvable. A Matlab® script was written to simulate partitioning depicted in Figure 6. 
In the simulation shown in Figure 6, cA = 0.03 M, cD = 0.01 M, r = 0.01 and 100, oaK  = 
5000 M−1, and 0
A−
P = 0.01.  
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Figure 6. Effect of the phase volume ratio: r = 0.01 (solid) and 100 (dashed). Dotted 
line depicts Equation (19). cA = 0.03 M, cD = 0.01 M, r = 0.01 and 100, oaK  = 5000 M
−1, 
and 0
A−
P = 0.01. 
Figures 2 and 6 illustrate that the phase volume ratio has a much smaller effect on the 
distribution coefficient than the Galvani potential. In Figure 7, the effect of the phase 
volume ratio on the Galvani potential is simulated with the same set of parameter values 
as in Figure 6. 
 
Figure 7. Effect of the phase volume ratio: r = 0.01 (solid) and 100 (dashed) on Galvani 
potential. 
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As can be seen, the Galvani potential is shifted only about 25 mV at low pH when the 
phase volume ratio is changed from 0.01 to 100. 
To summarize, the simulations that take into account the Galvani potential difference, 
phase volume ratio and pH show that at low pH, the deviation of the distribution 
coefficient from the generally used formula can be as much as two units on the log P 
scale. It is thus clear that all of these effects must be considered when evaluating the 
partitioning of ionized drugs as changing one value changes the others as well. The next 
section will present an overview of the experimental methods that can be used to study 
the partitioning of drugs. 
2.2 Experimental approaches 
The traditional experimental approach to drug partitioning is the measurement of the 
octanol−water partition or distribution coefficient by determining the equilibrium 
concentrations of a drug in both of the phases of an octanol−water mixture. Even though 
some studies have shown fairly good correlations of the octanol−water distribution 
coefficients with biological permeation [17,18], poor correlations have also been 
reported [8,19], suggesting that the octanol−water system does not account for all of the 
aspects of biological permeation. Some of the shortcomings of an octanol−water system 
as a partitioning model have been explained by the hydrogen bonding of a drug, which 
is very different in n-octanol compared with a biological membrane [20]. Thus 
alternatives for the octanol−water partition coefficient have been proposed in order to 
improve the biomimetics of the partitioning studies. Many of the popular experimental 
approaches utilize various model membranes, such as cell culture monolayers, artificial 
membranes, or liposomes. The most frequently used cell cultures for passive drug 
transport studies are Caco-2 cultures, which are derived from human colon carcinoma 
cells [21]. In Caco-2 cultures, the monolayers of the polarised cells, which mimic the 
function of the small intestinal villus epithelium, are grown on permeable filter supports 
and the transport of drugs through the monolayer is measured. In the parallel artificial 
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membrane permeation assay (PAMPA), on the other hand, the two compartments are 
separated by a hydrophobic filter impregnated with an organic solution of lipid, which 
forms bilayer structures in the filter pores [22]. Even though both of these techniques 
are extensively used, both the Caco-2 system and PAMPA seem to suffer from 
interlaboratory variability [23,24]. 
Because of their excellent biomimetic properties, liposomes have become a popular 
alternative in membrane partitioning studies. Liposome−water partition coefficients 
have been measured using various methods, including the distribution technique [25], 
equilibrium dialysis [26], potentiometric titration [6,9], and NMR-spectroscopy [27]. 
Despite the better biomimetic properties of liposomes, most of the approaches based on 
liposomes as model membranes are not efficient enough to be used on a large scale as 
they are very tedious and time-consuming. To overcome the problem in efficiency, 
automated methods for the rapid screening of drug compounds have been developed, 
where the biomimetic properties of liposomes have been combined with 
chromatographic techniques [28,29]. 
In this thesis, a new electrochemical method was developed for the determination of the 
liposome−water partition coefficient (Publication I). Also, isothermal titration 
calorimetry was used to evaluate the drug−liposome interactions (Publication IV).    
Additionally, the adsorption coefficients of drugs on model surfaces determined using 
surface activity and contact angle measurements were correlated with the partition 
coefficients in Publication III. Thus this thesis aims at exploring the various possibilities 
of physicochemical and electrochemical methods in studying the interactions of drugs 
with model biological membranes. 
2.2.1 Electrochemical methods 
Electrochemistry is a useful tool especially when studying ionized drugs. The use of 
liquid−liquid electrochemistry as a means to determine the ionic partition coefficients of 
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drugs was first presented in 1992 by Kontturi and Murtomäki [30]. The method is based 
on the determination of the standard free energy of transfer of ionized drugs at the 
interface of two immiscible electrolyte solutions. Unfortunately, the ionic free energies 
of transfer in Equation (8) cannot be obtained directly from experimental results. 
Because of this, an extrathermodynamic assumption has to be made to define a scale for 
the standard Gibbs energy of transfer of a single ion. Kontturi and Murtomäki utilized 
the commonly used the TATB assumption, which states that the cation and the anion of 
tetraphenylarsonium tetraphenylborate (TPAs+TPB− or TATB) have equal standard free 
energies of transfer for any pair or solvent: 
0
TPB
w
o
0
TPAs
w
o −+ Δ=Δ GG          (34) 
This assumption is based on the fact that both the cation and the anion have similar size 
and shape and are symmetrical. Thus their energies of solvation can be considered 
equal. 
The standard transfer potential of an ionic drug can be obtained from a cyclic 
voltammogram as it is related to the half wave potential: 
⎥⎥
⎥
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where Di and γi are the diffusion and activity coefficients of the drug in the appropriate 
phases respectively.  
The traditional solvent used in the partition studies, n-octanol, cannot be used in 
electrochemical measurements because electrolytes do not dissolve in it. In their studies, 
Kontturi and Murtomäki [30] used an organic phase consisting of 1,2-dichloroethane 
(DCE). Indeed, the water/DCE system preferred in liquid−liquid electrochemistry has 
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been suggested to be a more useful system when compared with the traditional 
water/alkane in determining the interactions of solutes with biological membranes [31]. 
In the later studies, nitrophenyl octyl ether (NPOE) has also been used as an organic 
solvent because of its suitable viscosity, vapour pressure and hydrophobicity [32,33]. In 
addition, NPOE has been reported to be a suitable solvent for the permeability assays 
with the PAMPA technique [34]. 
In the study of Scholz et al. [35], the limitations due to the low solubility of the 
electrolytes in some organic solvents have been overcome by the introduction of a 
three-phase electrode technique. The basis of the technique is an electrochemical system 
where three different phases, a solid electrode, an organic liquid, and an aqueous phase 
are brought into contact. A droplet of an organic solution of an electroactive compound 
is immobilized on the electrode surface and the electrode is then immersed into an 
aqueous solution containing the anionic form of a drug. By applying a potential 
difference between the working and the reference electrode, it is possible to study the 
electrochemical processes at the three phase junction.  
At the three phase boundary, the electrochemical reaction of the electroactive species 
decamethylferrocene (dmfc) in the organic phase is coupled with the transfer of the 
anionic form of the studied drug across the organic solvent−water interface. This 
process can be described by the following reaction scheme: 
dmfc (o)   +  D− (w)      →←         dmfc
+ (o)  +  D− (o) + e−    (I) 
Now the standard transfer potential can expressed as: 
( ) ⎟⎠
⎞⎜⎝
⎛
+−φΔ+= + 2lnln
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w
0
/dmfcdmfcf o
c
F
RTc
F
RTEE ii
o
     (36) 
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where Ef is the formal redox potential of the couple dmfc/dmfc+, 0 /dmfcdmfc oo+E   the 
standard redox potential of the couple in the organic phase, cdmfc is the concentration of 
dmfc in the organic phase and ci is the concentration of the anionic form of the drug in 
the aqueous phase. As the standard transfer potential is determined, the partition 
coefficient of a drug can be obtained using Equation (5). 
The advantage of the three-phase electrode technique over the traditional liquid−liquid 
electrochemistry is that the measurements do not require an additional electrolyte in the 
aqueous phase, but the studied species can be present alone and in high concentrations. 
No electrolyte is necessary in the organic phase either. In the work of Gulaboski et al. 
[36], the partition coefficients of anionic drugs and model compounds were determined 
using the three electrode approach in nitrobenzene (NB) and NPOE and then compared 
with values determined in the n-octanol−water system [37]. The lipophilicity range for 
the studied anions was wider for NPOE and NB than for n-octanol, which was 
interpreted as a larger difference in the solvation energies of anions between water and 
NPOE or NB than between n-octanol and water. The effects of ionic radii, charge 
delocalization, and the molecular size on the lipophilicity of the compounds were also 
evaluated in the study, with unusually high lipophilicity values reported for compounds 
containing a pyrrole ring. 
As an extension to the determination of the partition coefficient of various drugs, 
liquid−liquid electrochemistry has been used to construct ionic partition diagrams for 
solutes, which resemble the Pourbaix pH-potential diagrams for metals [15,38]. In these 
diagrams, the charged state and phase of a coumpound is presented as a function of the 
interfacial Galvani potential difference and pH of the solution. The purpose of the 
diagrams is to help to visualize the lipophilicity of different species present in a system. 
The diagrams are particularly useful in pharmacokinetics when determining which 
species of a multiprotic drug are present at a certain pH and potential and describing the 
transfer process of a drug. After the first pH dependence studies by Reymond et al. [15], 
the efficiency of the experimental setup has been improved first by the introduction of a 
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96-well microfilter plate system [33] and later by the use of a commercial immobilized 
pH gradient gel [39]. 
A major limitation of the partitioning studies at the liquid−liquid interface is that the 
organic solvents used in the studies do not mimic the properties of a biological 
membrane very well. After the first studies of Kontturi and Murtomäki [30], however, 
the biomimetic properties of liquid−liquid interface were improved by adding a 
monolayer of lipids at the interface [40−42]. The combination of Langmuir trough and 
electrochemistry allowed not only the control of the potential drop across the interface 
but also the control of the surface pressure. Using this system, Grandell et al. [40−42] 
studied the transfer of two model drugs, propranolol and picrate, across the interface. It 
was found that more energy was required to transfer picrate across the interface with the 
lipid compared with one without it. In addition, picrate was found to have a stabilizing 
effect on the lipid monolayer, whereas the transfer of propranolol was found to 
destabilize it. The water/DCE system was further improved in the works of Liljeroth et 
al. [43] and Mälkiä et al. [44,45]. In these studies, a biological membrane was modeled 
by depositing a lipid monolayer at the interface between the aqueous phase and an 
immobilized, gelled organic phase using the Langmuir-Blodgett technique. The 
Langmuir-Blodgett technique provided a better control of the surface pressure, as it was 
not controlled in situ, but the monolayer was transferred to the interface in its desired 
state. In addition, the gelled organic phase reduced the monolayer dissolution to the 
organic phase and the smaller interfacial area improved the quality of the 
electrochemical data. This set-up was used to study the membrane activity of six ionized 
drugs [44,45]. As a result, a preferential orientation of the drugs in the phospholipid 
monolayer was proposed for each drug.  
In Publication I, an electrochemical method was developed for the determination of the 
liposome−water partition coefficients of drugs. Square wave voltammetry (SWV) was 
used to study the interactions of liposomes and β-blockers at a water–DCE interface 
created at the tip of a micropipette. Five different β-blockers, propranolol, timolol, 
26 
 
 
carteolol, nadolol and metoprolol were encapsulated in liposomes prepared using the 
extrusion method. The partitioning of the drugs between the cavity and the membrane of 
the liposome was determined using an electrochemical set-up shown in Figure 8. 
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Figure 8. Schematic illustration of the experimental set-up. (Reprinted from Publication 
I with permission from Elsevier) 
Within the available potential window, which was determined by the supporting 
electrolytes used, the β-blocker was the only species transferring across the 
liquid−liquid interface. Diffusion of the liposomes to the interface, their decomposition 
at the contact with the organic phase, the subsequent release of the drug, and the transfer 
of the drug across the interface was observed as a peak current.  
The relationship between the peak current and the concentration of the ionic species for 
hemispherical diffusion is given by Equation (37) [46]: 
 p2/1
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π
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t
czFADi          (37) 
where Δip is the peak current, F is the Faraday constant, A the area of the micropipette 
tip, D the diffusion coefficient, Δψp a dimensionless peak current, tp the pulse width, c 
the bulk concentration of the transferring species, and z is the charge. The simplest 
27 
 
 
method for determining the dimensionless peak current is to compare the measurement 
with that of a known solution.  
The liposome−water partition coefficient of the drug was determined from the peak 
current using the following model: Partition coefficient is defined as the ratio of the 
activity a species in two immiscible phases in equilibrium. In this work, drugs partition 
between the aqueous cavity of the liposome and the lipid bilayer. For simplification, the 
activities can be approximated by concentrations: 
w
l
c
cP =           (38) 
where cl is the concentration of drug in the lipid bilayer and cw is the concentration 
inside the cavity.  
The concentration inside the cavity can be assumed to be that of the solution used in the 
preparation of the liposomes, and the concentration of drug in the lipid layer can be 
solved as the total amount of drug in a liposome is known: 
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where cl is the concentration in the bilayer, nl the amount of drug in the bilayer, z the 
total number of drug molecules in a liposome measured using square wave 
voltammetry, and NA is the Avogadro constant.   
The amount of drug in the cavity, zc, can be calculated from the drug concentration 
inside the liposome and the size of the cavity: 
3w
Ac 3
4 acNz π=          (40) 
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where cw is the concentration of the drug used in the preparation of liposomes and a is 
the radius of the liposome. Vl is the volume of the lipid bilayer given by: 
haV 2l 4π=           (41) 
where h is the thickness of the bilayer, which was taken to be 5 nm [47]. The log P 
values determined for each β-blocker are shown in Figure 9. 
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Figure 9. Liposome−water partition coefficients of the five β-blockers. (Reprinted from 
Publication I with permission from Elsevier) 
The results shown in Figure 9 demonstrate that the partition coefficient of ionized drugs 
can be determined using the method described in Publication I. Compared to partition 
coefficients determined by other methods, the method presented here gives log P values 
of the same order of magnitude as liposome−water partition coefficients determined 
using liposome distribution studies [48] and equilibrium dialysis [10]. The results also 
suggest that the liposome−water partition coefficients are somewhat lower than the 
respective octanol−water partition coefficients. The comparison of the octanol−water 
partition coefficients and liposome−water partition coefficients is shown in Figure 10. 
The measured values shown are average values of the determined partition coefficients. 
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Figure 10. Comparison of log Poctanol values and log Pliposome values. (Reprinted from 
Publication I with permission from Elsevier) 
The method presented in Publication I is a fast and easy way to determine the partition 
coefficient for ionized drugs. It provides some advantages for studying drug−membrane 
interactions compared with traditional methods: As the method utilizes 
electrochemistry, the system is easily controllable and the measurements can be carried 
out quickly. Also, because of the liposomes, the partitioning in the system mimics the 
real cell membrane partitioning quite accurately.  
Liquid−liquid electrochemistry is a versatile approach in drug partitioning studies as the 
setup enables the control of the potential difference across the interface and the study of 
ion transfer. The most evident drawback of the approach has been that the properties of 
the organic phase deviate from those of the biological membrane. Earlier, the 
biomimetic properties of experimental setup have been improved by incorporating lipid 
monolayers in the interface of the two immiscible electrolytes. Publication I, however, 
solves the biomimetic problem by introducing liposomes in the aqueous phase.  This 
method not only utilizes the rapidity of the electrochemical measurement, but also 
allows the determination of the liposome−water partition coefficient, which has been 
shown to correlate with the pharmacokinetic parameters in humans [25]. As the method 
can be applied to a wide range of ionized molecules with varying lipohilicity, it 
provides a new electrochemical tool for the drug partitioning studies. 
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2.2.2 Isothermal titration calorimetry  
One of the available methods to study the interactions of drugs with liposomes is 
isothermal titration calorimetry (ITC), which is an effective method for the study of 
binding in biological systems, as it allows for the determination of the Gibbs energy 
(ΔG), the enthalpy (ΔH), and the entropy of binding (ΔS) in a single experiment 
[49−52]. The thermodynamics of interactions between drugs and membranes can be 
related to the structural details of the process. The formation or breaking of non-
covalent bonds in the system is observed as ΔH, whereas ΔS gives a quantitative value 
of the change in order of the system. ITC has been applied to various drug−membrane 
systems. Seelig and coworkers [53−56] have studied the interaction of liposomes with 
various amphiphilic compounds including calcium channel antagonists and local 
anesthetics. In the work of Matos et al. [57], the thermodynamics of the membrane 
binding of anti-inflammatory drugs was evaluated in a broad concentration range. In 
addition to calorimetric studies on their own, ITC has been used to complement studies 
carried out mainly using other methods. Gerebtzoff et al. [58] used ITC combined with 
surface activity measurements to study the effect of halogenation of drugs on the 
membrane binding. In the study of Johansson et al. [59], calorimetric liposome partition 
data was used to validate the partition coefficients measured using an alternative model 
membrane, the sterically stabilized bilayer disks. In both of these studies, ITC data was 
reported to be in good agreement with the complementary data.  
In Publication IV, ITC and zeta potential measurements were used to study the binding 
and partitioning of four β-blockers and one local anaesthetic into liposomes. Two types 
of titrations, drugs into liposomes and liposomes into drugs, were compared to check 
the reliability of the data. The enthalpy, entropy and Gibbs energy of binding were 
determined using the one site model and the electrostatic contribution to the binding 
was evaluated using the Gouy-Chapman theory. Furthermore, the binding constants 
were used to assess the partition coefficients for the drugs, and additionally the effects 
of the concentration, ionic strength, temperature and membrane curvature on the 
interaction were included in the evaluation. 
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Figure 11 shows the titration of 10 mM alprenolol, labetalol, propranolol and tetracaine 
into 100 nm liposomes. The binding of these drugs into liposomes is an exothermic 
process as the titration peaks are negative. The heat produced decreases continuously 
until all of the binding sites in the liposomes are occupied and the heat of interaction is 
observed to be close to zero. The monotonous decrease of the amount of heat produced 
after each injection suggests that there is only one type of binding site in the liposomes. 
In addition, the zeta potential measurements mimicking the titrations revealed that the 
effect of the addition of the drugs on the zeta potential is very small and thus the zeta 
potential is practically constant during the titration. 
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Figure 11. Titration of alprenolol (▲), labetalol (●), propranolol (■) and tetracaine (♦) 
into 100 nm liposomes at 25 °C. The buffer used was 2 mM Hepes + 15 mM NaCl, pH 
7.4. The upper panel shows the raw ITC data for alprenolol and the lower panel the 
integrated enthalpies of interaction as a function of the ratio of drugs to lipids. The solid 
line represents the best fit using the one site model. (Reprinted from Publication IV with 
permission from Elsevier) 
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The one site model provided by the ITC software and used in the determination of the 
thermodynamic parameters is equivalent to the chemical equilibrium, where one drug 
reacts with a cluster of n lipids forming a complex of DLn. Therefore, the partition 
coefficients of the ionized drugs can be evaluated by multiplying the binding constant 
with the concentration of free lipids [51]: 
Pion = KbcL,f          (42) 
These partition coefficients describe drug partitioning as an overall process, which 
consists of various contributions, including the electrostatic effects, steric hindrance and 
hydrophobic interactions. 
The usual practice in binding studies is to separate the electrostatic contribution from 
the other factors. The most widely used method for this is to correct for the increased or 
decreased concentration of drugs near the charged surface. This is usually done with the 
Gouy-Chapman theory [53−58], although other methods have also been proposed [57]. 
The Gouy-Chapman theory assumes that a smooth surface has a charge density smeared 
out uniformly, as electrons do in metals [46]. This surface charge is the origin of the 
electrostatic potential field, in which point charges, i.e. ionic sizes excluded, are 
distributed according to the Boltzmann distribution, assuming the solvent as a 
continuous dielectric medium. Even though the continuum is a very simplistic model of 
the liposome surface, it can be used to correct for the ‘true’ interfacial concentration: 
⎟⎠
⎞⎜⎝
⎛ φ−= 0exp RT
Fzcc ibi
s
i         (43) 
where ‘s’ denotes the interfacial and ‘b’ the bulk concentration, and φ0 is the Galvani 
potential at the interface, zi is the ionic charge, F = 96486 Cmol−1, R = 8.314 JK−1mol−1 
and T is the absolute temperature.  
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The apparent value of the binding constant, Kapp, which takes into account the 
electrostatics of the binding, is: 
⎟⎠
⎞⎜⎝
⎛ φ−= 0bapp RT
FzKK i          (44) 
In Publication IV, the Gouy-Chapman theory was used to estimate the surface potential 
φ0 from the zeta potential, ζ. The Galvani potential profile at the interface was 
calculated using the following equation [46]: 
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In Equation (45), the distance x2 at which the potential corresponds to the zeta potential 
is taken to be 2.8 Å, which is the diameter of a water molecule.  
The reciprocal of the double layer thickness κ (Debye length) is given by: 
2/1
0r
22b2
⎟⎟⎠
⎞
⎜⎜⎝
⎛
εε
=κ
RT
Fzc          (46) 
where εr is the relative permittivity of water, 78.4, and ε0 is the permittivity of free 
space, 8.854 ×10-12 Fm-1.  
As the zeta potential values were almost unaffected by the addition of the drugs and no 
concentration dependency could be deduced, the average value of the zeta potential was 
used for each drug. Also, it was possible to evaluate the degree of ion binding using the 
equation for surface charge σ [46]: 
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In the evaluation, the solution was taken to be 1:1 electrolyte with the concentration of 
17 mM. Taking into account the size of the vesicle, the charge number of a liposome 
was calculated to be approximately 2500, which means that less than 5 % of the lipids 
are charged, although 30 w-% of the lipids are anionic. The calculation shows that the 
degree of the ion binding of sodium ions is high and explains why the effect of the 
addition of drugs on the zeta potential value is only minimal during the titration. 
As the electrostatic interactions play a major role in the interaction of cationic drugs 
with negatively charged membranes, the effect of the ionic strength was studied by 
carrying out the experiments at a different salt concentration, in 20 mM Hepes buffer 
containing 150 mM NaCl. The measurements revealed that the binding constant Kb is 
significantly lower at the higher ionic strength for all drugs. Lower values of Kb at 
higher ionic strength can be explained by the ion binding phenomenon. In the case of 
the high NaCl concentrations, Na+ ions compete with the drugs in binding the 
negatively charged membrane. The system can be analyzed by means of statistical 
thermodynamics. The grand canonical partition function for competitive binding is: 
q = 1 + K1c1 + K2c2         (48) 
where K1 and K2 are the binding constants for the drug and for the Na+ ion, respectively, 
and c1 and c2 are the respective concentrations.  
Writing the surface coverage of a drug (θ1) in terms of the two binding constants gives: 
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Figure 12 shows a simulation of the effect of salt concentration on the surface coverage 
of the drug. The simulation compares the salt concentrations of 0.01 M, 0.1 M and 1.0 
M. The binding constant for the drug is taken as 1000 M−1, and the binding constant for 
the Na+ ion as 10 M−1 [60].  
 
Figure 12. Effect of salt concentration on the binding constant. Concentrations of NaCl 
1 M (···), 0.1 M (---) and 0.01 M (solid line). (Reprinted from Publication IV with 
permission from Elsevier) 
 
From Figure 12, it is evident that the increase of the salt concentration by a factor of ten 
increases the equivalence point, i.e. the reciprocal of the binding constant, 
approximately by a factor of two and thus decreases the binding constant accordingly. 
As the effect of ionic strength on the binding of drugs in the ITC measurements was 
even greater than this, ion binding explains the results only partially. The structural 
organization of the lipids may also account for the phenomenon, as the ionic strength 
affects not only the electrostatics of the binding of the drugs, but also the organization 
of the lipids in the bilayer [61,62]. Moreover, it has been shown that phospholipid 
bilayers become more resistant to penetration as the ionic strength increases [63,64]. 
The apparent values of the binding constant determined in 2 mM Hepes, 15 mM NaCl at 
25 oC, the average zeta potentials and the calculated partition coefficients are 
summarised in Table 1. The liposome−water partition coefficient of propranolol is very 
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close to the value reported in Publication I (Figure 10). The consistent values given by 
the two different methods give support to the fact that ITC and the electrochemical 
method presented in Publication I are both reliable tools in drug partitioning studies. 
Table 1. Apparent binding constant, zeta potential and the logarithm of the partition 
constant for the binding of drugs into 100 nm liposomes at 298 K. The subscript D→L 
denotes the drug-into-liposome and L→D the liposome-into-drug titration (Reprinted 
from Publication IV with permission from Elsevier) 
Drug Kapp ×10−3 (M−1) ζ−potential (mV) Log PD→L Log PL→D 
Alprenolol 33 −24 2.2 2.0 
Labetalol 24 −33 2.0 1.8 
Propranolol 85 −37 2.5 2.4 
Tetracaine 62 −30 2.4 2.1 
 
2.2.3 Surface chemistry 
As the partitioning studies with lipid bilayers are usually rather time consuming, 
methods based on the surface active properties of drugs have been proposed for the 
determination of the partition coefficient. As an alternative to the lipid−water partition 
coefficient, Seelig and coworkers [65] have developed an approach based on the Gibbs 
equation of a drug. In this method, an air−water partition coefficient is determined by 
measuring the surface pressure of a drug monolayer at the air−water interface and 
applying the Szyszkowski equation [66]. The basis of the approach is that the 
partitioning of drugs at the air−water interface is assumed to be similar to the 
partitioning at the lipid−water interface, as the partitioning into both interfaces is driven 
by the hydrophobic effect, and because the dielectric constant for air is close to that for 
the hydrocarbon region of the lipid membrane [65]. Using the surface activity 
measurements, the ability of a drug to reach the central nervous system was predicted 
using three parameters derived from the adsorption isotherm: the minimum 
concentration at which surface activity is induced, the surface area of a molecule, and 
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the critical micelle concentration (CMC). Based on these parameters, drugs were 
divided into three groups: i) very hydrophobic that cannot pass the blood-brain barrier, 
ii) less hydrophobic that cross the blood brain barrier with ease and iii) hydrophilic 
drugs that cross the barrier only if applied at high concentrations. Later the method was 
also used to evaluate the effect of halogenation of drugs on membrane permeation [58]. 
It was found that the increased hydrophobicity due to halogenation increases the 
air−water partition coefficient. 
Even though the surface activity measurements were suggested to be suitable for fast 
screening of drug candidates, the experiments presented by Seelig and coworkers were 
rather time consuming. The measurement of a Gibbs adsorption isotherm took from 45 
minutes to four hours depending on the size of the trough used [65]. A new platform for 
the surface activity measurements was introduced in the work of Suomalainen et al. 
[67], where the measurements of drugs were carried out using a multichannel 
microtensiometer, which allowed fast measurement of surface activity of drugs with 
small sample volumes. 
Despite the comparable dielectric constants of air and the hydrocarbon core of a 
membrane, air is no more than a very crude model for the hydrocarbon region. To 
improve the biomimetics of the surface activity measurements, hydrocarbon−water 
interfaces were used in Publication III to study partitioning of drugs. As in the studies of 
Fisher et al. [65] and Suomalainen et al. [67], the Gibbs equation was used to determine 
the partition coefficient for the adsorption of the drugs. However, instead of measuring 
the surface pressure at air−water interface and applying the Szyszkowski equation to 
determine the partition coefficient, the Langmuir adsorption isotherms were constructed 
using surface tension measurements combined with contact angle data measured at the 
hydrocarbon−water interface (Figure 13). The hydrocarbon region of the lipid 
membrane was modeled using three different self-assembled monolayers (SAMs) on 
Au(111) surfaces, two of which were formed of alkanethiols of different chain lengths 
and one of the thiolipid 1,2-dipalmitoyl-sn-glycero-3-phosphothioethanol (DPPTE). The 
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adsorption coefficients of six β-blockers were determined and compared to the 
octanol−water partition coefficients as well as liposome−water partition coefficients. 
 
Figure 13. A schematic illustration of the experimental set-up in contact angle 
measurements (a) and an image of a drop of 1 mM propranolol solution on DPPTE 
SAM (b). (Reprinted from Publication III with permission from Elsevier) 
 
Partitioning of β-blockers into the interface can be described by the Gibbs equation, 
which relates the surface excess (Γ) to the chemical potential (μ) of the drug: 
⎟⎟⎠
⎞⎜⎜⎝
⎛
μ∂
∂
−=Γ SLγ           (50) 
where R is the gas constant, 8.314 J mol−1 K−1, T is temperature and γSL is the 
solid−liquid interfacial tension.  
Since the solid−liquid interfacial tension cannot be obtained directly from the contact 
angle measurements, the Young equation can be used to rewrite the Gibbs equation in 
terms of the contact angle θ and the liquid−vapor interfacial tension γLV. The Young 
equation represents the mechanical equilibrium of a drop under the action of the three 
interfacial tensions: 
SVLVSL cos γ=θγ+γ          (51) 
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where γSV is the solid−vapor interfacial tension. Substituting γSV into the Gibbs equation, 
assuming γSV constant, gives: 
( )
μ∂
θγ∂
=Γ cosLV          (52) 
Thus, the surface excess can be determined from the graph of γLVcos θ versus μ by 
taking the derivative at each data point. The chemical potential of the drug can be 
approximated by the infinite dilution limit as: 
( )∗= ccRT /lnddμ          (53) 
where c is the concentration of the drug and c* is 1.0 mol dm-3. 
In Publication III, the surface excesses of the drugs at each concentration were 
determined using equation (52). The Langmuir adsorption isotherm was used to 
evaluate the partition coefficients of the drugs. The Langmuir isotherm describes the 
equilibrium between the drug molecules in the aqueous solution and those partitioned at 
the surface: D + S   →←       DS. The adsorption coefficient for the equilibrium is K = 
[DS]/([D][S]), where [DS] is the concentration of the drug at the surface, [D] is the 
concentration of the drug in the aqueous phase, and [S] is the concentration of 
unoccupied sites at the surface. The adsorption coefficients for the partitioning of the 
drugs were determined by fitting the Langmuir isotherm to the data, as the surface 
excess at each drug concentration was known: 
Kc
Kc
+
Γ
=Γ
1
max           (54) 
where Γmax is the maximum surface excess and c is the concentration of the drug.  
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The maximum surface excess values determined from the fit varied from 8 × 10-11 mol 
cm-2 to 1.6 × 10-9 mol cm-2. These values are comparable to the ones reported in the 
study of Nguyen et al. [68], where a novel deep-ultraviolet spectroscopic method was 
used to study the association of drugs to the planar supported lipid bilayers. The values 
determined in this study using the Langmuir isotherm were from 10-12 mol cm-2 to 10-11 
mol cm-2, which are only slightly smaller than the ones determined in Publication III. 
The difference in the magnitude of the surface excesses of different drugs has been 
suggested to be due to the repulsive interactions between drug molecules, which are 
stronger for some drugs than the others [68]. 
The adsorption coefficient K determined using Equation (54) can be compared to the 
traditional octanol−water partition coefficient Poct, as both of the coefficients describe 
the equilibrium between the phase mimicking the hydrocarbon region of the membrane 
and the aqueous phase. When the logarithm of K was compared to the logarithm Poct, it 
was evident that log Koctadecanethiol correlated very well with log Poct (Figure 14a, R2 = 
0.95), whereas no correlation was observed between log Kdecanethiol and log Poct (Figure 
14b). The difference is probably due to the less-ordered structure of the decanethiol 
SAM compared with the octadecanethiol SAM. As the lipid molecules in the 
phospholipid bilayer of the biological membranes are relatively tightly packed and well-
ordered [69], the results suggest that the ability of the decanethiol surface to serve as a 
model membrane is not as good as that of the octadecanethiol SAM. 
Interestingly, log KDPPTE correlated fairly well with log Poct (Figure 14c, R2 = 0.86), 
even though the maximum surface excess of the drugs determined at DPPTE SAMs 
were somewhat different from those determined at the alkanethiol SAMs. Compared 
with the octadecanethiol SAM, the correlation of log KDPPTE with log Poct was slightly 
lower and the structural properties of the SAMs may account for this difference. The 
isotropic hydrocarbon phase in the octadecanethiol SAM is very similar to the octanol 
phase, whereas the DPPTE SAM is more anisotropic due to the phosphorus moiety of 
the DPPTE molecule. Because of this, it was interesting to compare the log K values not 
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only to the log Poct values, but also to the log Plip values, the liposome−water partition 
coefficients. 
To compare the adsorption coefficients and the liposome−water partition coefficients, 
the log Plip values for metoprolol, nadolol, propranolol and timolol were taken from 
Publication I and log Plip for alprenolol was obtained from the literature [10]. 
Unfortunately, log Plip for labetalol was not available. Comparison of log Koctadecanethiol 
and log Plip is shown in Figure 14d (R2 = 0.69), and that of log KDPPTE and log Plip in 
Figure 14e (R2 = 0.70). No correlation was found between log Kdecanethiol and log Plip, 
and this lack of correlation is probably due to the less-ordered structure of the 
decanethiol monolayer as discussed above. As can be seen from Figures 14d and 14e, 
there is no difference in the correlation of log Koctadecanethiol and log KDPPTE and both log 
Koctadecanethiol and log KDPPTE correlate better with log Poct than with log Plip. Poor 
correlation with log Plip can be explained by the anisotropy of the liposomal membrane.  
Due to the excellent biomimetic properties of liposomes, log Plip describe well the 
whole partitioning process of the drug into the membrane, which includes multiple 
barriers for the drugs. In addition to the hydrocarbon core of the membrane, the two 
polar headgroup interfaces act as diffusion barriers. Because of the simplicity of the 
model membranes used in this study, the log K values mainly describe the barrier 
properties of the hydrocarbon core of the bilayer membrane and should not be 
interpreted as mimicking the partitioning process as a whole. Moreover, good 
correlation with the traditional log Poct supports the interpretation that the method 
presented in Publication III gives insight into the interaction of drugs with the 
hydrophobic core of the biological membrane. 
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Figure 14. Correlation of log Koctadecanethiol with log Poct (a), log Kdecanethiol with log Poct 
(b), log KDPPTE with log Poct (c), log Koctadecanethiol with log Plip (d), and log KDPPTE with 
log Plip (e). (Reprinted from Publication III with permission from Elsevier) 
The purpose of Publication III was to demonstrate how surface tension and contact 
angle measurements on different SAMs can be used to assess drug−membrane 
interactions. When data obtained using the pendant drop method and contact angle 
goniometry were fitted to the Gibbs equation and the Langmuir isotherm, it was 
possible to determine the adsorption coefficient K. It was found that log K determined 
on the octadecanethiol and DPPTE SAMs correlated very well with log Poct and fairly 
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well with log Plip whereas no correlation was found between log K on the decanethiol 
surface and log Poct or log Plip. It was concluded that the ability of the decanethiol SAM 
to model the hydrophobic core of the membrane is not as good as that of the 
octadecanethiol SAM or DPPTE SAM due to its less ordered structure. In addition, 
comparison of the relative magnitudes of the surface excesses of the drugs on the 
alkanethiol SAMs versus those on DPPTE SAMs revealed that it is not only 
hydrophobicity, but also the conformational effects that are decisive factors in drug-
membrane interactions.  
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3 Physicochemical properties of drug carriers 
3.1 Liposomes 
Liposomes are used as pharmaceutical carriers for a wide variety of drugs, including 
antitumor and antimicrobial agents, chelating agents, peptides, proteins and genetic 
material [70]. Depending on the physicochemical properties of the drug, it can be 
captured in the aqueous cavity of the liposome, interact with the bilayer surface or be 
taken up by the bilayer structure. The pharmacological properties of a liposomal drug 
formulation depend on the physicochemical properties of the liposomal carrier and the 
drug as well as the strategies used for drug encapsulation and retention [71]. 
In Publication I, the ability of liposomes to encapsulate and carry drugs was utilized in 
an electrochemical determination of the partition coefficient. Five β-blockers with 
varying lipophilicity were encapsulated in POPC/POPG liposomes and the amount of 
drug in the liposomes was determined using square wave voltammetry. Negatively 
charged liposomes were chosen because of their resemblance to biological membranes 
[72] and because the preliminary experiments showed that more of a drug was 
encapsulated into these liposomes compared with the neutral ones. The better 
encapsulation efficiency is most probably due to the electrostatic contribution that 
dominates the binding of cationic drugs into the negatively charged membrane as 
explained in Publication IV. The higher encapsulation efficiency of cationic drugs into 
the negatively charged liposomes due to the electrostatic interaction has been reported 
also in the literature [73].  
Comparing the amounts of drugs incorporated into liposomes in Publication I, where the 
drugs were both in the bilayer and the aqueous cavity of the liposomes, and in 
Publication IV where the drugs were interacting with the surface of preformed 
liposomes, it is clear that less drugs were sequestered within the membrane in the latter 
case. When the drugs are added to the preformed liposomes, they do not penetrate 
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through the bilayer to the aqueous cavity, but reside on the surface of the liposome or 
partition into the hydrocarbon core of the membrane [74,75]. Various gradient driven 
methods have been developed to improve the loading efficiency when drugs are loaded 
after the formation of the membranes [76−78]. In this thesis, however, high drug 
loading was essential only in Publication I, where it was accomplished by passive 
loading during the hydration stage of the liposome preparation [79]. 
3.2 DNA complexes 
Carriers of drugs are especially important in gene delivery, as naked DNA crosses 
various barriers of the cell very inefficiently because of its size and charge. To facilitate 
the entry of DNA into the cell and the subsequent expression in the nucleus, a wide 
variety of carriers have been designed for gene delivery purposes. Due to the safety 
issues related to the viral vectors, more and more research has focused on nonviral 
vector systems including cationic lipids, polymers, dendrimers and peptides [80]. 
Various polymers have been tested as carriers of DNA, and their structures usually 
include protonable amines, the number and pKa of which is different in each carrier 
[81]. Two of the most commonly used polycations are poly-L-lysine (PLL) and 
polyethyleneimine (PEI). Both of these cationic polymers form small toroidal 
complexes with DNA [82], however, in vitro studies have shown that compared to PLL, 
the transfection efficiency of PEI is much higher [83,84]. The higher efficiency in gene 
transfer has been explained by its ability to buffer endosomes [83,85]. The buffering 
capacity of PEI results from its unique structure, as only a part of the amino groups in 
PEI are protonated at physiological pH.  
One major problem when using polymeric carriers is that the complexes tend to 
aggregate in aqueous solutions. The preparation conditions of polycation-DNA 
complexes influence the aggregation behavior. Generally the aggregates grow bigger in 
higher ionic strength, and as a result, the aggregation is more severe under physiological 
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conditions whereas in glucose solution the complexes aggregate to a lesser extent. Also, 
PEI/DNA complexes formulated in 5 % glucose have been shown to be more efficient 
in vivo than complexes prepared in 150 mM sodium chloride [86]. It has been proposed 
that the difference in efficiency is due to the difference in their aggregation behaviour in 
different media. Nevertheless, the aggregation phenomenon exists even in 5 % glucose, 
so a detailed knowledge on the phenomenon is crucial when improving the efficiency of 
gene carriers.  
The size of the DNA complexes formed using synthetic polymers has to be controlled in 
order to reach higher efficiency in gene delivery. Much research has already been done 
concerning the control of the size of the complexes and the prevention of the 
aggregation process. In most of the studies, the attempts to control the aggregation 
behaviour of polycations have either involved the right choice of environment and 
protocols of complexing [87,88] or the covalent attachment of protecting groups 
[89−91]. In the work of Lee et al. [92], aggregation of complexes was prevented by 
electrostatic attachment of cationic fusogenic peptides conjugated with poly(ethylene) 
glycol to negatively charged PEI/DNA complexes. Bromberg et al. [93] modified PEI 
with a diblock copolymer to protect the DNA complexes from aggregation in the 
presence of serum proteins. Also, biomaterial systems for controlled delivery of DNA 
have been used to overcome the aggregation problem [94,95]. Furthermore, it was 
proposed that the aggregation could be prevented by surfactants [96]. Sharma et al. [96] 
showed that the addition of the surfactant polyoxyethylene inhibits the aggregation 
process of PEI/DNA complex during 24 hours of storage. Control of aggregation is not 
only important during the storage of the gene medicine, but more importantly, 
controlling the size and charge of the complex is crucial when delivering the vector into 
a cell.  
Prior to entering the cell, DNA complexes may interact with various extracellular 
matrix components. Extracellular matrices contain sulfated proteoglycans consisting of 
a core protein covalently linked to one or more sulfated glycosaminoglycans (GAGs): 
heparin, heparin sulfate, dermatan sulfate, chondroitin sulfate or keratin sulfate [97]. 
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These negatively charged GAGs may bind to the positively charged DNA complexes on 
its way to the cell. GAGs have been shown to have a dual role in gene delivery. 
Whereas membrane associated GAGs have been suggested to mediate the binding and 
delivery of cationic complexes to the cell [98], many studies have also shown that 
extracellular GAGs can actually decrease the transfection efficiency of the non-viral 
carrier by blocking the access of the DNA complexes to the target cell [99−101]. If 
DNA is released from the complex upon interaction with GAGs, GAGs may be 
internalized into the cell with the free carrier instead of DNA [102]. Because of this, 
release of DNA by GAGs in the extracellular matrix is not desirable when designing 
new gene carriers.  
Publication II presents a comparison of the size and charge of the cationic polymer-
plasmid DNA (pDNA) complexes of two commonly used polymers, PEI and PLL. The 
complexation was studied in 5 % glucose solution at 25 °C using dynamic light 
scattering and isothermal titration calorimetry. The aggregation of the complexes was 
controlled by addition of the surfactant polyoxyethylene stearate (POES). In addition, 
the stability of the complexes in the presence of GAGs was evaluated using dextran 
sulfate (DS) as a relaxing agent. The relaxation of the complexes was studied using 
agarose gel electrophoresis.  DS is a highly charged polyanion and because of its 
resemblance with heparin, it can be used as a model molecule for extracellular matrix 
GAGs. Publication II elucidates the role of surfactant in controlling the size of the 
PEI/DNA complex and reveals the differences of the two polymers as complexing 
agents. 
In Publication II, it was found that at a certain nitrogen to phosphate (N/P) ratio POES 
reduced the size of the PEI/DNA complexes and prevented the aggregation over time. 
However, the addition of POES did not prevent the aggregation over the whole range of 
N/P ratios studied, but instead, the addition of POES shifted the aggregation process to 
a lower N/P ratio (Figure 15). It was also found that the higher the POES concentration, 
the more the aggregation peak was shifted to the direction of lower N/P ratios. 
Moreover, POES affected not only the size of the complexes, but also the zeta potential. 
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The measurements confirmed that the point of zero zeta potential was also shifted to the 
lower N/P ratios as the highest diameter of the complexes was measured to correspond 
to the zeta potential closest to zero.  
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Figure 15. Size of PEI/DNA complexes as a function of N/P ratio. The effect of POES. 
(Reprinted from Publication II with permission from Elsevier) 
The peaks observed in the size-N/P curve were related to the apparent pKa of the 
polycation and it was found that the addition of POES affected the extent of the 
protonation of PEI increasing its pKa value significantly. The shift in the pKa of PEI can 
be explained in terms of the change in the Gibbs energy. As the surfactant molecule is 
in the vicinity of the polycation, the shielding effect of the like charges is increased and 
the distance between the charges is altered. As the surfactant screens the charges, a 
greater fraction of the polycation can be protonated. From Coulombs law, the change in 
the Gibbs energy as the change in distance between the charges is: 
⎟⎟⎠
⎞
⎜⎜⎝
⎛
−−=Δ
210
A
2 11
4 rr
NeG
επε
        (55) 
where e is the elementary charge, NA the Avogadro constant, ε0 the permittivity of free 
space, ε the permittivity of water, and r1 and r2 are the separation distances of the 
charges.  
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On the other hand, the Gibbs energy is: 
aln KRTG −=Δ          (56) 
And the change in the Gibbs energy 
( )
2,a
1,aln
K
K
RTG −=ΔΔ          (57) 
which can be rewritten as: 
( ) a303.2 pKRTG Δ=ΔΔ         (58) 
Combining the equations (55) and (58) gives: 
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Assuming the distance between the charges of the polycation is 5 Å without the 
surfactant, the measured pKa change of 0.2 units by the addition of the surfactant results 
in r2 = 7.4 Å. Likewise, if the separation distance of the charges is 10 Å, r2 = 27.9 Å. 
Thus it is evident that very small changes in the distance between the charges shift the 
pKa value significantly. Unlike the PEI/DNA complexation, the PLL/DNA 
complexation was almost unaffected by the addition of POES.  
To study the aggregation process further, the thermodynamic parameters of the 
complexation were determined using ITC. ITC data revealed that the enthalpy changes 
related to the complexation process are minute. For PEI/DNA complexation, ΔH = −640 
cal mol–1 = −2678 J mol–1, which is of the same magnitude as the thermal energy RT. 
For PLL, the change in enthalpy was so small that it could not be detected. As the 
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change in entropy for the PEI/DNA complexation was measured to be 27 cal mol–1 K–1 
= 113 J mol–1 K–1 and the term TΔS 8046 cal mol–1 = 33.6 kJ mol–1, hence over ten-fold 
to the enthalpy contribution, the complexation process of pDNA with the polycation 
must be entropy driven. The results are also consistent with the values given in the 
literature for DNA binding with other polycations. The binding enthalpies determined 
for the complexation of DNA with (dimethylamino)ethyl methacrylate homopolymer 
varied from 0 kJ mol–1 to –6 kJ mol–1 of polymer, depending on the pH of the solution 
[103], whereas the binding enthalpies of the interaction of linear polyaminoamine 
polymer with DNA were from 0 kJ mol–1 to –3.5 kJ mol–1 [104]. Also binding 
enthalpies of the same magnitude, but of an endothermic nature have been observed: 
For the binding of DNA with trivalent cations cobalt hexamine and spermidine the 
enthalpies of binding ranged from 1 kJ mol–1 to 10 kJ mol–1 of cation [105] and for the 
binding of DNA with a cationic graft copolymer from 0 kJ mol–1 to 3 kJ mol–1 of 
copolymer [106]. The binding entropy of 113 J mol–1 K–1 is in accordance with the 
previously reported values for DNA binding with various polycations. In the entropy 
driven processes, the measured values of TΔS varied from 28 kJ mol–1 to 42 kJ mol–1 for 
the complexation of DNA with trivalent cations [105], and from 11 kJ mol–1 to 26 kJ 
mol–1 for a cationic graft copolymer [106].  
Plasmid DNA complexation and the stability of the complexes in the presence of DS 
was studied using gel electrophoresis. Only the free negatively charged pDNA was 
observed to migrate in the electric field whereas fully complexed pDNA could not be 
seen in the gel (Figure 16). Electrophoresis confirms the stabilizing effect of POES on 
the PEI/DNA complexes: PEI/DNA complex was relaxed upon addition of DS (lane 4), 
while PEI/DNA complexes stabilized by POES did not show this relaxation (lane 5). 
The results complement the findings of Sharma et al. [96]: POES not only prevents the 
aggregation of PEI/DNA complexes, but also stabilizes the complexes in the presence 
of extracellular GAGs. The GAG resistance developed with POES could be used as an 
alternative to the detergent removal method, where PEI/DNA complexes are protected 
against GAGs using a negatively charged lipid coating [107]. 
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Figure 16. Effect of dextran sulfate on the stability of PEI/DNA and PLL/DNA 
complexes. Marker (lanes 1 and 11), PEI/DNA (lane 2), PEI/DNA/POES (lane 3), 
PEI/DNA + DS (lane 4), PEI/DNA/POES + DS (lane 5), PLL/DNA (lane 6), 
PLL/DNA/POES (lane 7), PLL/DNA + DS (lane 8), PLL/DNA/POES + DS (lane 9), 
plasmid DNA alone (lane 10). (Reprinted from Publication II with permission from 
Elsevier) 
As a whole, Publication II presents a detailed study on the size and charge of the DNA 
complexes with two commonly used polycations PEI and PLL. The study also examines 
the effect of the surfactant POES on the complexation and elucidates the origin of the 
stabilizing effect of the surfactant. This area of research is important because knowledge 
on the interactions of surfactants with DNA complexes may help to adjust the size and 
charge of the gene carrier complexes to a desired value when designing new gene 
carriers.  
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4 Conclusions 
The purpose of this thesis was to study the interactions of drugs with biological model 
membranes using physicochemical and electrochemical techniques. The topic included 
not only the interactions of traditional drugs with various membrane models, but also 
those related to carriers of drug, as they are equally important in controlling the delivery 
of the drug to the target site of the body. 
When the ability of the drug to penetrate the cell membrane is assessed, one of the most 
widely used parameters is the partition coefficient of the drug. Publication I presents a 
novel electrochemical method for the determination of the liposome−water partition 
coefficient. The method utilizes square wave voltammetry in the determination of the 
amount of the drug encapsulated in the liposomes. A mathematical model was 
established to solve for the concentrations of drugs in the aqueous cavity and within the 
bilayer membrane, and as a result, the liposome−water partition coefficients for five β-
blockers were reported in Publication I. The study demonstrates that the electrochemical 
measurements combined with the biomimetic properties of liposomes provide a rapid 
method to assess the interactions of drugs with the phospholipid membranes using only 
minute quantities of reagents.  
In Publication IV, the binding of drugs onto liposomes was studied using ITC and zeta 
potential measurements. The thermodynamic parameters of enthalpy, entropy, Gibbs 
free energy and binding constant were reported for three β-blockers and one local 
anesthetic. The interaction of these drugs with liposomes was found to be enthalpy 
driven, with the electrostatics being the dominating factor. Increasing the ionic strength 
lowered the binding constant significantly, which was attributed to ion binding, 
although other contributions were also taken into account. Furthermore, the 
liposome−water partition coefficients obtained from the binding constants corrected for 
the electrostatic effect were determined to be somewhat lower that the corresponding 
octanol−water partition coefficients. Comparing the partition coefficients of Publication 
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I and IV, the liposome−water partition coefficient of propranolol determined using ITC 
in Publication IV corresponded very well with the electrochemically obtained value 
reported in Publication I. 
The interactions of drugs with the hydrophobic part of the biological membrane were 
assessed using contact angle goniometry and surface tension measurements (Publication 
III). The hydrophobic core was modeled with two different alkanethiols and one 
thiolipid attached onto a gold surface. The adsorption coefficients of drugs on these 
hydrophobic model surfaces were found to correlate better with the octanol−water 
partition coefficients than with the liposome−water partition coefficients determined in 
Publication I. Because of the simplicity of the contact angle and surface tension 
measurements, it would be interesting to apply this approach also to other biomimetic 
surfaces, such as supported lipid bilayers. 
The interactions of drugs with its carriers were explored in Publication II, which focuses 
on the properties of plasmid DNA-polycation complexes. It was shown that the 
aggregation of PEI/pDNA complexes can be controlled with the surfactant POES, 
which also protects the complexes against the negative effects of extracellular GAGs. 
These findings are particularly relevant for ocular gene delivery, as the membranes in 
the eye have a very high content of GAGs. 
As a whole, this thesis addresses a number of important aspects of drug-membrane 
interactions from the physicochemical perspective. Various approaches to the 
partitioning of drugs were explored and three different experimental methods were used 
to determine the partition coefficients of eight drugs. Furthermore, physicochemical 
explanations were presented for a broad range of phenomena, ranging from the 
electrostatics of the binding of drugs to the aggregation of the DNA complexes. 
Understanding these interactions may prove to be useful not only when studying the 
transport of drugs in the body, but also when designing new drugs. 
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